MARK SCHOENEBAUM, MD

Corporate Board Profile

Tech Score: 0/100

TG THERAPEUTICS, INC.

Filing Date	Source Excerpt
2018-04-30	Mark Schoenebaum, M.D., 45, has served on our Board since April 2012. The Compensation Committee currently consists of all independent members of our Board of Directors, with Mr. Hoberman as chairman. The following table sets forth the cash and other compensation paid by the Company to the members of the Board for all services in all capacities during 2017. Mark Schoenebaum, M.D.: Fees Earned or Paid in Cash $55,412, Stock Awards $166,500, Total $221,912.

Filing Date

Source Excerpt

2018-04-30

Mark Schoenebaum, M.D., 45, has served on our Board since April 2012. The Compensation Committee currently consists of all independent members of our Board of Directors, with Mr. Hoberman as chairman. The following table sets forth the cash and other compensation paid by the Company to the members of the Board for all services in all capacities during 2017. Mark Schoenebaum, M.D.: Fees Earned or Paid in Cash $55,412, Stock Awards $166,500, Total $221,912.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22